0000002230-19-000029.txt : 20190322 0000002230-19-000029.hdr.sgml : 20190322 20190322161005 ACCESSION NUMBER: 0000002230-19-000029 CONFORMED SUBMISSION TYPE: N-CEN/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190322 DATE AS OF CHANGE: 20190322 EFFECTIVENESS DATE: 20190322 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADAMS DIVERSIFIED EQUITY FUND, INC. CENTRAL INDEX KEY: 0000002230 IRS NUMBER: 134912740 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CEN/A SEC ACT: 1940 Act SEC FILE NUMBER: 811-00248 FILM NUMBER: 19699937 BUSINESS ADDRESS: STREET 1: 500 EAST PRATT STREET STREET 2: SUITE 1300 CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 4107525900 MAIL ADDRESS: STREET 1: 500 EAST PRATT STREET STREET 2: SUITE 1300 CITY: BALTIMORE STATE: MD ZIP: 21202 FORMER COMPANY: FORMER CONFORMED NAME: ADAMS DIVERSIFIED EQUITY FUND DATE OF NAME CHANGE: 20150331 FORMER COMPANY: FORMER CONFORMED NAME: ADAMS EXPRESS CO DATE OF NAME CHANGE: 19920703 N-CEN/A 1 primary_doc.xml X0201 N-CEN/A LIVE 0000002230 XXXXXXXX 811-00248 N-2 Adams Diversified Equity Fund, Inc. 811-00248 0000002230 5493005W7G81BNPP7M23 500 East Pratt Street Suite 1300 Baltimore 21202 US-MD US 410-752-5900 Adams Diversified Equity Fund, Inc. 500 East Pratt Street Suite 1300 Baltimore 21202 410-752-5900 All accounts, books, and documents required to be maintained by the Registrant pursuant to Section 31(a) of the Investment Company Act of 1940 and Rules 31a-1 through 31a-3 thereunder are maintained at the office of the Registrant except all those relating to the activities of the Fund's Custodian and Transfer Agent. The Northern Trust Company 50 South La Salle Street Chicago 60603 312-630-6000 All accounts, books and documents relating to the activities of the Fund's Custodian and Securities Lending Agent. American Stock Transfer and Trust Company, LLC 6201 15th Avenue Brooklyn 11219 718-921-8200 All accounts, books and documents relating to the activities of the Fund's Transfer Agent. Y N N-2 Y Mark E. Stoeckle N/A Y Enrique R. Arzac N/A N Kenneth J. Dale N/A N Frederic A. Escherich N/A N Roger W. Gale N/A N Lauriann C. Kloppenburg N/A N Kathleen T. McGahran N/A N Craig R. Smith N/A N Janis F. Kerns N/A 500 East Pratt Street Suite 1300 Baltimore 21202 XXXXXX Y N N N N N PricewaterhouseCoopers LLP 238 N/A N N N N N Adams Diversified Equity Fund, Inc. 5493005W7G81BNPP7M23 Y N/A N N Y N N The Northern Trust Company 6PTKHDJ8HDUF78PFWH30 N N Revenue sharing split Administrative fee Cash collateral reinvestment fee 38224374.000000000000 62724.000000000000 N/A N N N N American Stock Transfer and Trust Company, LLC 084-00416 254900TS5EWP83BEOU02 N N N ICE Data Pricing & Reference Data, LLC 5493000NQ9LYLDBCTL34 N N The Northern Trust Company 6PTKHDJ8HDUF78PFWH30 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N American Stock Transfer and Trust Company, LLC 254900TS5EWP83BEOU02 N N N N Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 471690 Sanford C. Bernstein & Co., LLC 8-52942 000104474 549300I7JYZHT7D5CO04 98955 Deutsche Bank Securities Inc. 8-17822 000002525 9J6MBOOO7BECTDTUZW19 76344 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 64578 Credit Suisse Securities (USA) LLC 8-422 000000816 1V8Y6QCX6YMJ2OELII46 58695 Stifel Nicolaus & Co. Inc. 8-1447 000000793 5WUVMA08EYG4KEUPW589 49672 Barclays Capital Inc. 8-41342 000019714 AC28XWWI3WIBK2824319 43791 Cowen & Company, LLC 8-22522 000007616 549300WR155U7DVMIW58 42201 Robert W. Baird & Co. Inc. 8-497 000008158 549300772UJAHRD6LO53 34936 Empirical Research Partners LLC 8-65590 000123520 N/A 29326 1164360 Fidelity Distributors Corporation 8-8775 000006848 549300XG82GC06JU1803 45001685 Legg Mason Investor Services, LLC 8-53089 000109064 N/A 40000000 85001685 Y 1809865811 Common stock N/A N N Common stock N N N 0 0.56 12.62 14.89 false false true false false false false false false false false INTERNAL CONTROL RPT 2 ADX.txt Report of Independent Registered Public Accounting Firm To the Board of Directors and Shareholders of Adams Diversified Equity Fund, Inc. In planning and performing our audit of the financial statements of Adams Diversified Equity Fund, Inc. ("the Fund") as of and for the year ended December 31, 2018, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund's internal control over financial reporting. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A companys internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a companys assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Funds internal control over financial reporting and its operation, including controls over safeguarding securities that we consider to be material weaknesses as defined above as of December 31, 2018. This report is intended solely for the information and use of the Board of Directors of Adams Diversified Equity Fund, Inc. and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. /s/ PricewaterhouseCoopers LLP Baltimore, MD February 15, 2019